Table V.

Regional LNs metastases in 163 patients with No. 12p and No. 12b metastases.

	LNs metastases (n, %)	No. 12p/b metastases (n, %)	P value
No. 1	56/163 (34.4)	7/15 (46.7)	0.292
No. 2	33/117 (28.2)	5/15 (33.3)	0.869
No. 3	93/163 (57.1)	13/15 (86.7)	0.015
No. 4sa	17/117 (14.5)	3/15 (20.0)	0.801
No. 4sb	23/163 (14.1)	5/15 (33.3)	0.064
No. 4d	35/163 (21.5)	6/15 (40.0)	0.133
No. 5	27/163 (16.6)	9/15 (60.0)	0.000
No. 6	12/163 (7.4)	3/15 (20.0)	0.148
No. 7	45/163 (27.6)	9/15 (60.0)	0.003
No. 8a	19/163 (11.7)	4/15 (26.7)	0.139
No. 9	8/163 (4.9)	3/15 (20.0)	0.027
No. 10	18/117 (15.4)	3/15 (20.0)	0.883
No. 11	16/163 (9.8)	2/15 (13.3)	0.631
No. 12a	21/163 (12.9)	8/15 (53.3)	0.000

No. 1 = right paracardial; No. 2 = left paracardial; No. 3 = lesser curvature; No. 4a = along short gastric vessels; No. 4sb = along left gastroepiploic vessels; No. 4d = along right gastroepiploic vessels; No. 5 = suprapyloric; No. 6 = infrapyloric; No. 7 = along left gastric artery; No. 8a = anterosuperior group; No. 9 = around celiac axis; No. 10 = splenic hilum; No. 11 = along splenic artery; No. 12a = along hepatic artery in the hepatoduodenal ligament.